Home/Celularity/Darren Sigal
DS

Darren Sigal

Scientific Advisory Board Co-Chairperson

Celularity

Celularity Pipeline

DrugIndicationPhase
Placental-derived biomaterial productsWound care / Tissue regenerationApproved/Commercial
MLASC-based therapiesDegenerative DiseasesPhase 1/2
NK Cell therapiesOncologyPhase 1/2
T Cell therapiesImmunology/OncologyPhase 1/2